• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down1.54% Nasdaq Down1.52%

    Corcept Therapeutics Incorporated (CORT)

    -NasdaqCM
    5.96 Down 0.07(1.16%) Apr 17, 4:00PM EDT
    |After Hours : 5.96 Down 0.00 (0.01%) Apr 17, 4:22PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Dec 31, 2013Dec 31, 2012
    Total Revenue 26,551   10,357   3,307  
    Cost of Revenue882  143  91  
    Gross Profit 25,669   10,214   3,216  
    Operating Expenses
    Research Development18,372  20,470  14,074  
    Selling General and Administrative34,916  31,240  25,414  
    Non Recurring -   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (27,619) (41,496) (36,272)
    Income from Continuing Operations
    Total Other Income/Expenses Net -   -   -  
    Earnings Before Interest And Taxes(27,619)(41,496)(36,272)
    Interest Expense3,764  4,515  1,776  
    Income Before Tax(31,383)(46,011)(38,048)
    Income Tax Expense -   -   -  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(31,383)(46,011)(38,048)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (31,383) (46,011) (38,048)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (31,383) (46,011) (38,048)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.